FDA approves Leqselvi for severe alopecia
The U.S. Food and Drug Administration has approved Leqselvi (deuruxolitinib) tablets for the treatment of adults with severe alopecia areata.
Aug 3, 2024
0
55
Enzymes and Coenzymes: News and Research on Janus Kinase 1
MeSH tree: D08.811.913.696.620.682.725.124.100
Evaluation of ruxolitinib, a JAK inhibitor, in multiple myeloma
A new research perspective titled "Preclinical and clinical evaluation of the Janus Kinase inhibitor ruxolitinib in multiple myeloma" has been published in Oncotarget.
Feb 7, 2024
0
40
